Notably, GANT-61 also reduced pericyte coverage and dextran leakage, as indicated by the presence of α-SMA-positive cells surrounding CD31-positive cells and the relative fluorescence intensity in the tumor tissues (Fig. 8I-L). This evidence concerns the gene ACTA1 and neoplasm.